Citadel Advisors - CALUMET SPECIALTY PRODS PTNR ownership

CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 71 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.9%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CALUMET SPECIALTY PRODS PTNR
ValueSharesWeighting
Q3 2023$13,594,330
+7.5%
711,745
-10.7%
0.00%0.0%
Q2 2023$12,645,670
-10.4%
797,331
-1.8%
0.00%0.0%
Q1 2023$14,112,299
+23.3%
811,985
+19.8%
0.00%
+50.0%
Q4 2022$11,444,488
+95.3%
677,991
+48.2%
0.00%
+100.0%
Q3 2022$5,861,000
+57.6%
457,565
+27.8%
0.00%
Q2 2022$3,720,000
-11.5%
357,941
+15.9%
0.00%
Q1 2022$4,205,000
-42.0%
308,903
-43.7%
0.00%
-100.0%
Q4 2021$7,246,000
+406.0%
548,963
+203.2%
0.00%
Q3 2021$1,432,000
+1.1%
181,062
-12.3%
0.00%
Q2 2021$1,417,000
-25.1%
206,370
-33.5%
0.00%
Q1 2021$1,893,000
+102.9%
310,314
+4.1%
0.00%
Q4 2020$933,000
+8.1%
297,965
-12.0%
0.00%
Q3 2020$863,000
+12.4%
338,614
+0.4%
0.00%
Q2 2020$768,000
+585.7%
337,122
+215.1%
0.00%
Q1 2020$112,000
-82.4%
107,000
-38.6%
0.00%
Q4 2019$636,000
-39.3%
174,200
-39.5%
0.00%
Q3 2019$1,048,000
-39.6%
287,882
-30.5%
0.00%
Q2 2019$1,735,000
+10.5%
413,943
-6.1%
0.00%
Q1 2019$1,570,000
+10.9%
441,002
-31.2%
0.00%
Q4 2018$1,416,000
-49.6%
640,632
+45.9%
0.00%
Q3 2018$2,811,000
+4.5%
439,134
+21.7%
0.00%
-100.0%
Q2 2018$2,689,000
+9.7%
360,822
+3.8%
0.00%0.0%
Q1 2018$2,451,000
-4.1%
347,566
+4.7%
0.00%0.0%
Q4 2017$2,555,000
+55.1%
331,835
+68.3%
0.00%
+100.0%
Q3 2017$1,647,000
+214.9%
197,226
+60.2%
0.00%
Q2 2017$523,000
+284.6%
123,114
+246.1%
0.00%
Q1 2017$136,000
-34.6%
35,569
-31.5%
0.00%
Q4 2016$208,000
+342.6%
51,926
+399.3%
0.00%
Q3 2016$47,000
-87.5%
10,400
-67.4%
0.00%
Q1 2016$375,000
+55.0%
31,929
+162.2%
0.00%
Q4 2015$242,000
+55.1%
12,178
+89.0%
0.00%
Q3 2015$156,000
-64.3%
6,444
-62.4%
0.00%
Q2 2015$437,000
-30.1%
17,146
-34.0%
0.00%
-100.0%
Q1 2015$625,000
+463.1%
25,978
+423.8%
0.00%
Q4 2014$111,000
-46.4%
4,960
-34.4%
0.00%
Q3 2014$207,000
+38.9%
7,558
+61.3%
0.00%
Q2 2014$149,000
-78.2%
4,685
-82.2%
0.00%
-100.0%
Q1 2014$682,000
+66.7%
26,376
+67.7%
0.00%0.0%
Q4 2013$409,000
+282.2%
15,728
+300.3%
0.00%
Q3 2013$107,000
-54.7%
3,929
-39.5%
0.00%
Q2 2013$236,0006,4980.00%
Other shareholders
CALUMET SPECIALTY PRODS PTNR shareholders Q3 2023
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 2,249,209$7,040,0007.61%
Adams Asset Advisors, LLC 4,555,224$14,257,0003.90%
KNOTT DAVID M 2,645,000$8,279,0003.75%
Springhouse Capital Management, LP 356,722$1,117,0001.08%
Barnett & Company, Inc. 309,882$969,0000.61%
Windsor Wealth Management, Inc. 206,176$645,0000.16%
Danda Trouve Investment Management, Inc. 17,738$56,0000.07%
O'Brien Greene & Co. Inc 33,001$103,0000.04%
Plancorp, LLC 45,000$141,0000.04%
Accel Wealth Management 10,306$32,0000.03%
View complete list of CALUMET SPECIALTY PRODS PTNR shareholders